23948sdkhjf
Log in or create to bookmark articles
Get access to all content on Life Science Nordic
No commitment or card information required
Applies to personal subscription only.
Contact us for a enterprise solution.
Advertisement
Advertisement

New antibody aims to slow kidney damage – “It’s kind of cool”

For 25 years, Marie Jeansson has studied the kidney and its blood vessels. She is now working on developing a drug intended to slow down chronic kidney disease.
Advertisement

Globally, more than 850 million people are estimated to suffer from chronic kidney disease. In Sweden, more than 10 percent of the population is believed to have some degree of this common condition, which can, for example, be caused by diabetes-related complications.

Many people are unaware that they have the disease, says Marie Jeansson, associate professor at Karolinska Institutet in Huddinge and Uppsala University, in an interview with Life Science Sweden.

Advertisement Advertisement
BREAKING
{{ article.headline }}
0.156|instance-web03